Exploring RSV Vaccination and Cardiac Health

This chapter analyzes findings from the DAN RSV trial, highlighting the benefits of bivalent RSV vaccination on reducing all-cause cardiorespiratory hospitalizations in older adults. It also delves into the implications of high-dose influenza vaccination and the connection between clonal hematopoiesis and increased cardiac risk, raising critical insights for future research.